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Resumo
Mioma submucoso pode diminuir a
probabilidade de uma concepção espontânea
e, portanto, ser uma causa de falha
reprodutiva.
Existem variados métodos para tratamento
de mioma(s) submucoso(s). A escolha da
melhor forma de tratamento deve ter em
conta as características do mioma: o tamanho,
número (único ou múltiplo), localização e sua
relação com a cavidade uterina/miométrio;
Além disso, a idade da mulher e seu desejo
de procriação têm grande influência na
escolha do melhor método de tratamento.
As técnicas endoscópicas intra-uterinas são
actualmente amplamente utilizadas e
consideradas procedimentos cirúrgicos
minimamente invasivos.
Apresentamos um caso de uma mulher
nulípara de 32  anos, a tentar engravidar,
diagnosticada com um grande mioma uterino
submucoso (5,8 cm de maior diâmetro). Foi
realizada a ressecção do mioma por
ressectoscopia cirúrgica com sucesso.
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Abstract
Submucous myoma(s) can decrease the
chances of  a spontaneous conception and,
therefore, be a cause of  reproductive failure.
There are many different methods for
submucous myoma(s) treatment. The choice
for the best treatment approach should take
into account the characteristics of  the
myoma: the size, number (single or multiple),
location and its relationship with the
myometrium/uterine cavity; Also, the age of
the woman and her desire for procreation
have great influence when choosing the best
treatment method.
The intrauterine endoscopic techniques are
currently widely used and considered
minimally invasive surgical procedures.
We present a case of  a 32-year-old nulliparous
woman, attempting to get pregnant, who was
diagnosed with a large submucous uterine
myoma. A successful resection, of  a 5,8 cm
greater diameter submucous myoma, was
made by resectoscopic surgery.
Key-words
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Introduction
Uterine fibroids, also known as uterine myoma, leiomyoma,
fibromyoma or fibroleiomyoma, are the most common benign
tumours found in the female genital tract. They can be detected
in approximately 20– 25% of  women in reproductive age. [1,2]
Of  all characteristics of  a myoma, it is believed that location
is the main factor determining the frequency and severity of
symptoms. Submucous myomas represent 5-10% of  all uterine
fibroids [3] and they are one of the causes responsible for
signs/symptoms such as: increased blood loss during menstrual
period causing, subsequently, anemia, dysmenorrhoea and/or
infertility.[1-2, 4]
Submucous myomas can be classified according to its extent
of  penetration into the myometrium. Therefore, submucous
myoma G0 is the one that is completely within the uterine
cavity, connected only by a thin pedicle to the uterine wall; G1
has its larger part >50% protruding into the uterine cavity,
while G2 has its larger part >50% within the myometrium.[5]
Laparotomic myoma excision or hysterectomy, have long been
the common surgical treatment approaches for symptomatic
submucous myomas.[6]
However, due to creation of  new/better instruments and
development of  new surgical techniques, endoscopic
myomectomy has spread worldwide as a standard treatment
method for submucous myomas.[7]
We present a successful case of  a resectoscopic resection of  a
large submucous uterine myoma in a nulliparous woman.
Case report
Nulliparous 32-year-old woman, with irrelevant medical
history, trying to get pregnant during the last 2 years. She came
to the urgency department because of  heavy and prolonged
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menstrual period. The physical gynaecological examination
was completely normal, except for the confirmation of  heavy
bleeding. She referred that her cycles were regular (28 days),
but her menstrual period duration was getting longer, superior
to 8 days in the last 3-6 months, associated with heavy bleeding.
She did not refer other symptoms such as dysmenorrhoea or
dyspareunia. She also denied history of  epistaxis, gingivorrhagia
or easy bruising after trauma.
The blood count was normal except for haemoglobin of
10.9gr/dL normocytic normochromic.
A transvaginal ultrasound scan was performed and revealed
the suspicion of  a submucous myoma with 5 cm greater
diameter.
She was discharged from the urgency department on the same
day, medicated with continuous combined oral
estroprogestative and iron, up to her gynaecological
consultation. A hysterosonography was performed and
confirmed the existence of  a submucous myoma, located in
the anterior-left uterine wall,  with 5,8 cm greater diameter,
with its larger part (>50%) in the uterine cavity (G1) – see
figure 1 and 2. After explaining the advantages and
disadvantages of  the various options of  treatment, the removal
of  the myoma by resectoscopic surgery in one or two-step
procedure was proposed and accepted by the patient.
The resectoscope chosen for surgery was the bipolar Fr
resectoscope (Gynecare) with the 2.5mm cutting loop.
After entering the uterine cavity, the G1 submucous myoma
was visualized measuring subjectively 6 cm greater diameter.
The myoma was completely removed after this single, 55
minutes duration, surgical approach. There were no
complications during the procedure. The patient was
discharged on the same day, 7 hours after the surgery.
Continuous combined oral estroprogestative and iron were
maintained till the 21st pos-operative day.
The pathological examination revealed leiomyoma.
A transvaginal ultrasound scan/hysterosonography was
performed after her first pos-operative menstrual period, which
occurred immediately after the suspension of  the combined
oral estroprogestative therapy. There were no abnormal
findings during the imaging examination, confirming the
surgery success in the complete removal of  submucous myoma
- see figure 3.
Fig. 1 - 2D hysterosonography of  the submucous myoma (Voluson E8 system
(GE Healthcare, Zipf, Austria))
Fig. 2 - 3D hysterosonography of  the same submucous myoma (Voluson
E8 system (GE Healthcare, Zipf, Austria))
Fig. 3 - Empty uterine cavity, confirmed by hysterosonography, after
successful resectoscopic resection of  the submucous uterine myoma (Voluson
E8 system (GE Healthcare, Zipf, Austria))
Discussion
Nowadays there is sufficient scientific evidence that allows us
to state that myomas, especially those with submucous
component, can have a negative impact on fertility.[8] Our
case represents a nulliparous woman, trying to get pregnant,
with heavy and prolonged menstrual periods.
After making the diagnosis of  submucous myoma by
transvaginal ultrasound scan, we decided to perform also a
hysterosonography in order to better characterize the myoma
location, size and its relationship with the uterine cavity/
myometrium. Using the STEP-W submucous fibroid
classification proposed by Lasmar RB[9], our case would be
classified as: Size >5cm (score 2); Upper topography (score
2); Extension of  the base <1/3 (score 0); Penetration <50%
(score 1); reaching the uterine lateral wall (score 1); total score:
6, which corresponds to group II – high complexity
hysteroscopic myomectomy. Hysteroscopy could be another
possibility, with advantages such as allowing performing biopsy
of  the neoformation or characterizing the endometrium.
However, in our point of  view, besides being a more expensive,
painful and technically more difficult exam when compared
with hysterosonography, there is the possibility of  the myoma
to sink into the myometrium/uterine wall due to an increase
intracavitary uterine pressure by the distension medium,[10]
leading to an erroneous classification of  the myoma.
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There are many different surgical treatment approaches for
submucous myoma removal. Abdominal hysterectomy and
uterine artery embolization were immediately excluded towards
a nulliparous woman who aims to become pregnant. We also
decided not to opt for laparoscopic myomectomy, since this
would involve the opening of  the uterine wall till the cavity,
which may distort the uterine cavity and/or create endometrial
or pelvic adhesions compromising fertility and/or the woman’s
future obstetric outcome, since the risk of  uterine rupture is
not negligible and the mode of  delivery would probably be an
elective caesarean section.
Intrauterine endoscopic myomectomy is a recent treatment
option with high efficiency rate and the advantage of  being a
minimally invasive surgical procedure. There are several
different techniques for this kind of  surgical approach:
resectoscopic myoma removal; ablation by neodymium-
yttrium-aluminum-garnet (Nd:yAG) laser; vaporization of
myoma; intra-uterine morcellation. Of  these methods we chose
to perform a resectoscopic excision of  the submucous myoma
since: vaporization or laser ablation besides being more costly
methods and technically more difficult to perform because
of  gas bubbles formation that can reduce operator visibility,
they also do not allow to collect material for histopathologic
examination; when compared with resectoscopic myomectomy,
hysteroscopic morcellation seems to reduce intraoperative time
in 8 to 26 minutes.[11, 12] Nevertheless, this technique is
limited to treat myomas with intramural component and is
still lacking data about long term outcome and/or comparison
of  perioperative complications.[13]
The resectoscopic myoma removal was performed using the
classical technique of  ablation by slicing, characterized by
repeated and progressive movements of  the cutting loop,
starting on the top and distal part of  the myoma, towards
proximal part till the base of  the myoma.
Hysteroscopic myomectomy may be associated with various
complications, such as: laceration of  the cervix, uterine wall
perforation, haemorrhage, excessive fluid absorption, urinary
tract and/or bowel lesions.  In our case, excessive fluid
absorption was one of  our main concerns, mainly due to the
fact that myomectomy of  larger fibroids are usually more time-
consuming procedures. Precautions were taken in order to
avoid this kind of  complication: we tried to maintain the
intrauterine fluid pressure as low as possible as long as we had
optimal visualization and stop the procedure, either if  the
operating time exceeds more than 1 hour, or if  the fluid deficit
reaches 1 or 2 liters maximum, especially in young healthy
patients, like in our case. Furthermore, the fibroid resection
of our case neither had moderate or major bleeding, nor had
the need of  large endometrium ablation that are two main
risk factors responsible for complications related to increased
absorption of  fluid.
The best surgical approach regarding the size of  the myoma is
still controversial. Myomas G1 should not be bigger than 5–
6cm, while myomas G2 should not exceed 4–5 cm, to be
removed by intra uterine endoscopic techniques.[14]
There is also a debate whether women with submucous
myomas should be treated or not with GnRH analogs prior to
surgery. Donnez[15] et al suggested that myomas with less than
2cm diameter do not require any pre surgical treatment.
Moreover, GnRH agonist should be a treatment option for
those women with myomas exceeding 4cm. Okohue[16] made
a literature review about if  there is a role for preoperative
treatment with GnRH agonist and concluded that GnRH
agonist used prior to hysteroscopic myomectomy probably
helps reducing the size of  the myoma and improving
haemoglobin level, especially in anemic patients. Nevertheless,
Campo[6] et al after comparing resectoscopic myomectomy
with and without pretreatment with GnRH analogs in
premenopausal women stated that the administration of
GnRH agonist, although improving haemoglobin values in
women with secondary anemia, did not resulted in better short
and/or long term outcome following the intra uterine
endoscopic procedure. Since the level of  the haemoglobin of
our patient was not a concern, we decided not to administer
GnRH agonist. Instead we opted for continuous combined
oral estroprogestative and iron therapy in an attempt to induce
amenorrhea, to recuperate haemoglobin to normal values and
better possibility of  surgical scheduling.
In conclusion, preoperatively characterization / imaging
mapping of  the myoma (size, topography, extension of  the
base of  the myoma, penetration into the myometrium) is
essential for surgical planning. Also, resectoscopic
myomectomy can be a safe and minimally invasive surgical
approach for large submucous myomas, especially in
nulliparous women that are attempting to become pregnant.
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